http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111424014-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-105 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2510-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2500-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2500-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-165 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-115 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0693 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-09 |
| filingDate | 2020-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-111424014-B |
| titleOfInvention | Culture medium of immortalized cell strain of human jugular auxiliary nerve ganglionic tumor |
| abstract | The invention provides a culture medium for an immortalized cell line of human jugular auxiliary neuroma, which at least comprises: the cell culture additive comprises human vascular endothelial growth factor, human epidermal growth factor, human basic fibroblast growth factor, human insulin growth factor, hydrocortisone succinate and vitamin C. The culture medium can effectively maintain the proliferation activity and physiological characteristics of the human jugular paraganglioma immortalized cell strain, is favorable for obtaining the jugular paraganglioma cell strain with stable growth passage and better physiological characteristics, and can realize large-scale culture of the cell strain. |
| priorityDate | 2019-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 126.